Exploring ultrasound characteristics in breast cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between various ultrasound characteristics, including conventional, elastography, and contrast-enhanced ultrasound (CEUS), and pathological prognostic factors in patients diagnosed with breast cancer. By utilizing radiomics, the study aims to uncover potential correlations that could enhance understanding of breast cancer pathology. The research focuses on gathering data from patients undergoing endocrine therapy and analyzing it to identify patterns that may inform treatment decisions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Clinical diagnosis of breast cancer

Exclusion Criteria:

Missing pathology Missing follow-up results Missing data

Where it's running

• the Second Affiliated Hospital Zhejiang University School of Medicine
  Hanzhou, Zhejiang, China Recruiting

Study contacts

• Principal investigator: pintong Huang — Second Affiliated Hospital, Zhejiang University, School of Medicine
• Study coordinator: zimei Lin
• Email: zimei.lin@zju.edu.cn
• Phone: +8615157171799

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Robotic versus sonographer breast ultrasound screening

  This trial will see if robotic ultrasound can find breast cancer as well as or better than a human sonographer in women aged 35–64 and will check how well they follow recommended follow-up care.

  Recruiting Huazhong University of Science and Technology · Xiantao, Hubei · NCT07331363

• Radiology-based prediction of HER2 level and T‑DXd benefit in metastatic breast cancer

  This study tests whether patterns in CT or FDG‑PET images can show HER2 level and help predict response to trastuzumab deruxtecan for people with metastatic breast cancer.

  Recruiting Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Milan · NCT07030569

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.